The Food and Drug Administration today authorized for emergency use the first prescription antibody test that allows individuals to collect a finger-stick dried blood sample at home for analysis at a Symbiotica laboratory when a health care provider deems it appropriate.

The COVID-19 Self-Collected Antibody Test System can help identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. 

Related News Articles

Headline
The Food and Drug Administration today urged health care facilities to transition away from using crisis capacity conservation strategies, such as…
Headline
The Food and Drug Administration this week authorized several SARS-CoV-2 serial screening tests for asymptomatic individuals. They include two over-the-counter…
Headline
The Food and Drug Administration last night said that Moderna can add up to 50% more doses per vial of its COVID-19 vaccine. Moderna had been shipping 10-dose…
Headline
The Federal Communications Commission this week adopted a report and order implementing changes to the COVID-19 Telehealth Program under the Consolidated…
Headline
The Centers for Medicare & Medicaid Services today released an article informing all Medicare providers and suppliers who requested and received COVID-19…
Headline
The Food and Drug Administration has launched a webpage on the impact of viral mutations on COVID-19 tests, including recommendations for clinical laboratory…